NSMCE2 Antikörper (C-Term)
Kurzübersicht für NSMCE2 Antikörper (C-Term) (ABIN783606)
Target
Alle NSMCE2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse, Rat
-
Aufreinigung
- Immunoaffinity Chromatography
-
Immunogen
- 15 amino acid peptide near the carboxy terminus of Human MMS21
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- NSMCE2 (E3 SUMO-Protein Ligase NSE2 (NSMCE2))
-
Andere Bezeichnung
- NSMCE2
-
Hintergrund
- MMS21, also known as NSE2, is a SUMO ligase that in combination with the SMC5/6 complex is required for the prevention of DNA damage induced apoptosis by facilitating DNA repair in human cells. MMS21-dependent sumoylation is integral and important to the cohesion mechanism and mitotic progression, this function appears to be independent of SMC6. MMS21 mediates SUMO attachment to various proteins such as SMC6L1 and TRAX, and possibly the cohesin components RAD21 and STAG2.Synonyms: C8orf36, E3 SUMO-protein ligase NSE2, MMS21
-
Gen-ID
- 286053
-
NCBI Accession
- NP_775956
-
UniProt
- Q96MF7
Target
-